Germany touts legal action on AstraZeneca over COVID-19 vaccine delays

By Nikita Chaurasia  | Date: 2021-02-02

Germany touts legal action on AstraZeneca over COVID-19 vaccine delays

Germany’s government has reportedly threatened legal action against pharmaceutical laboratories for failing to deliver COVID-19 vaccines to the European Union on schedule. The recent development comes amidst high tensions regarding vaccine delays from AstraZeneca plc, a British-Swedish pharmaceutical giant.

For those unaware, there has been a growing unease between AstraZeneca and European leaders, after the drug-maker had fallen behind on its promise of delivering enough COVID-19 vaccine to the region. The pharmaceutical giant had claimed that it could now only deliver a quarter of the assured vaccine doses owing to some issues in one of its European factories.

German Economy Minister Peter Altmaier mentioned in a statement that if the pharma companies do not comply with their obligations, the country will be forced to undertake legal action. He added that the regional companies cannot favor other countries over the European Union.

Brussels has also accused AstraZeneca of giving partial treatment to the United Kingdom for the delivery of its COVID-19 vaccine at the expense of the European Union, sources claimed.

The EU had briefly threatened to limit vaccine exports to Northern Ireland by intervening in a part of the Brexit deal with Britain that enabled the free flow of goods over the Irish border.

It is also worth noting that AstraZeneca is not the only drug-maker in the firing line. Sources confirmed that Italy had threatened legal action against Pfizer Inc., an American pharmaceutical company, over vaccine delivery delays.

Sources confirmed that the European Medicines Agency has recently approved the COVID-19 vaccine developed by AstraZeneca for use in the European Union, after clearing Coronavirus vaccines from Pfizer-BioNtech as well as Moderna Inc.

Speaking of which, American multinational pharmaceutical company Pfizer Inc. has reportedly vowed to deliver around 75 million COVID-19 vaccine doses to the European Union by spring of 2021.

Source Credits –

https://www.firstpost.com/world/germany-threatens-legal-action-as-tensions-rise-between-eu-and-astrazeneca-over-covid-19-vaccine-delays-9257381.html

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More >>

More News By Nikita Chaurasia

L&T Technology Services partners with Qualcomm to amplify 5G adoption

L&T Technology Services partners with Qualcomm to amplify 5G adoption

By Nikita Chaurasia

L&T Technology Services Limited has recently announced that it is teaming up with Qualcomm Technologies, Inc., the world’s leading wireless technology innovator. With the latest collaboration, the firm plans to offer end-to-end solutions...

PNAS, Straive partner to deliver end-to-end content production services

PNAS, Straive partner to deliver end-to-end content production services

By Nikita Chaurasia

Renowned U.S.-based nonprofit and non-governmental organization, NAS (National Academy of Sciences), has reportedly collaborated with Straive, one of the leading technology-driven solutions providers for Content, EdTech, and Data. With this acquis...

Japan pushes innovations in 'deep tech' sector with solar cell technology

Japan pushes innovations in 'deep tech' sector with solar cell technology

By Nikita Chaurasia

Amid the most promising next-generation solar cell technology innovations, Enecoat Technologies, a provider of materials development services in Japan, is reportedly developing perovskite. Following its completion, the Kyoto-located start-up expec...

GIC to acquire majority shares in opulent Sani/Ikos properties

GIC to acquire majority shares in opulent Sani/Ikos properties

By Nikita Chaurasia

Singapore's sovereign wealth fund, GIC has agreed to pay around $2.2 billion to buy a majority stake in Sani/Ikos Group, a Mediterranean luxury resort operator, marking the largest transaction in the European resort market since the Covid-19 pand...

Excelra, Patcore partner to offer enhanced digital insights to customers

Excelra, Patcore partner to offer enhanced digital insights to customers

By Nikita Chaurasia

Excelra, a data and analytics solutions provider, has recently announced its partnership with Patcore, Inc., to provide better access to its analytics products and scientific data for customers in Japan. For the unversed, Excelra is one of the top...